G
Giulia Ferrannini
Researcher at Karolinska Institutet
Publications - 44
Citations - 516
Giulia Ferrannini is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 23 publications receiving 323 citations. Previous affiliations of Giulia Ferrannini include Columbia University & University of Turin.
Papers
More filters
Journal ArticleDOI
Risk prediction in patients with diabetes: is SCORE 2D the perfect solution?
Journal ArticleDOI
Eligibility for vericiguat in a real-world heart failure population according to trial, guidelines, and label criteria: Data from the Swedish Heart Failure Registry.
N. V. Nguyen,F. Lindberg,Lina Benson,Giulia Ferrannini,Egidio Imbalzano,Peter G. M. Mol,Ulf Dahlström,Giuseppe Mc Rosano,Justin A. Ezekowitz,Javed Butler,Lars Lund,Gianluigi Savarese +11 more
TL;DR: In this paper , the eligibility for vericiguat in a real-world heart failure (HF) population based on trial, guidelines and label criteria was investigated, and the eligibility was calculated based on criteria from 1) the Vericuat Global Study in Subjects with Heart Failure and Reduced Ejection Fraction (VICTORIA) trial; 2) European and American guidelines on HF; 3) product labeling according to the Food and Drug Administration and European Medicines Agency.
Journal ArticleDOI
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK
Giulia Ferrannini,Mariam Almosawi,Kåre Buhlin,Ulf de Faire,Barbro Kjellström,Björn Klinge,Åke Nygren,Per Näsman,Elisabet Svenungsson,Lars Rydén,Anna Norhammar +10 more
TL;DR: In this long-term follow up of a contemporary, case-control study, the risk for cardiovascular events was higher in patients with a previous first MI compared with their matched controls, while mortality did not differ.
Journal ArticleDOI
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE
TL;DR: In this article , the associations between extreme weight changes and cardiovascular outcomes in two large randomised controlled trials of canagliflozin in patients with Type 2 diabetes and high cardiovascular (CV) risk were assessed.
Journal ArticleDOI
Gender differences in lifestyle management among coronary patients and the association with education and age: results from the ESC EORP EUROASPIRE V registry.
Pieter Vynckier,Giulia Ferrannini,Kornelia Kotseva,Sofie Gevaert,Dirk De Bacquer,Delphine De Smedt +5 more
TL;DR: Despite little gender differences in lifestyle advice provided by a healthcare professional, lifestyle compliance for physical activity is worse in CHD women, and further actions are needed to increase physical activity levels in female CHD patients.